Tuesday, April 21, 2026

UnitedHealthcare is removing prior authorization requirements for most services delivered by providers in rural areas. This is part of the payer's rural health financial stability initiative. The change is effective immediately for newly received requests and applies to both Medicare Advantage and commercial plans. Rural clinics should verify their eligibility for this policy via their UHC portal or representative. For eligible services, submit claims without waiting for auth. This directly impacts scheduling and revenue cycle speed for affected providers.

CMS formally proposed expanding the Comprehensive Care for Joint Replacement (CJR) model to all U.S. hospitals. This mandatory bundled-payment program for hip and knee replacements, currently active in select markets, would become national policy, tying payment to episode-of-care cost and quality. The proposal is part of the FY 2027 IPPS rule. Practices in orthopedics, physical therapy, and post-acute care must monitor for the final rule's terms, as this shift could alter referral patterns, discharge planning, and post-discharge billing workflows for a significant portion of Medicare volume.

The FDA and CMS announced a new joint initiative, the RAPID Coverage Pathway, designed to accelerate Medicare coverage of FDA-designated breakthrough medical devices. The program aims to coordinate FDA approval and CMS national coverage determination processes, reducing the lag time between market availability and reimbursement. The announcement details a framework for simultaneous review, targeting life-changing technologies for conditions like advanced heart failure and severe neurological disorders. This is a structural change, not an immediate coverage list. Practices specializing in cutting-edge interventions should monitor the CMS website for the first devices selected for the RAPID pathway later in 2026.

Representatives Pramila Jayapal (D-Wash.) and Ro Khanna (D-Calif.) introduced the "Improving Seniors' Access to Care Act," which would prohibit the use of prior authorization for medically necessary services under Medicare Advantage plans. The bill positions prior auth as a barrier to care and a driver of clinician burnout. While its prospects in a divided Congress are uncertain, the introduction signals sustained political pressure on MA utilization management practices. This follows CMS's recent proposed rule to streamline prior auth for drugs and UHC's voluntary rollback of some auth requirements in rural areas. Billing leaders should track the bill's progress (HR XXXX) as a marker of the regulatory direction, even if immediate passage is unlikely.

Amperos Health closed a $16 million Series A funding round led by Bessemer Venture Partners. The company's platform uses AI to automate the denial appeals process, identifying winnable cases and generating appeal letters. This funding signals continued venture capital investment in automating the back-end of RCM, particularly as payer denial rates remain high. While not a direct policy change, it highlights the market's focus on tools that address administrative burden. Billing managers evaluating denial management vendors should add Amperos to their competitive analysis.